Eurosurveillance · 2020 · 93 citations · 16 references
Life SciencesImmunologyInfectious DiseasesClinical ImmunologyMolecular VirologyVirologyDonor-specific AntibodiesSerological DiagnosticsSeroprevalence StudiesAntibodiesSars-cov-2 InfectionSevere Acute Respiratory SyndromeViral Seroprevalence
Most cases of coronavirus disease 2019 are mild or asymptomatic. Therefore, many cases remain unrecorded. We determined seroprevalence of IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 3,186 regular blood donors in three German federal states between 9 March and 3 June 2020. The IgG seroprevalence was 0.91% (95% confidence interval (CI): 0.58-1.24) overall, ranging from 0.66% (95% CI: 0.13-1.19) in Hesse to 1.22% (95% CI: 0.33-2.10) in Lower-Saxony.
16
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Seth Flaxman, Swapnil Mishra, Axel Gandy et al. · Nature · 2020 · 3.8K citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +11
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quanxin Long, Bai-Zhong Liu, Haijun Deng et al. · Nature Medicine · 2020 · 3.1K citations · Full text
Fan Wu, Aojie Wang, Mei Liu et al. · medRxiv · 2020 · 743 citations · Full text